Lantheus Holdings (LNTH) Long-Term Debt Repayments (2014 - 2026)

Lantheus Holdings (LNTH) reported Long-Term Debt Repayments of $216000.0 for Q1 2026, down 46.27% year-over-year from $402000.0 in Q1 2025, and down 38.81% quarter-over-quarter from $353000.0 in Q4 2025.

Lantheus Holdings (LNTH) Long-Term Debt Repayments (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Long-Term Debt Repayments data on file, last reported at $216000.0 in Q1 2026.

  • Long-Term Debt Repayments for Q1 2026 came in at $216000.0, down 46.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $924000.0 (up 72.39% YoY), and the FY2025 annual result was $1.1 million, up 249.06% from the prior year.
  • Long-Term Debt Repayments fell to $216000.0 in Q1 2026 per LNTH's latest filing, from $353000.0 in the prior quarter.
  • Over five years, Long-Term Debt Repayments peaked at $167.5 million in Q4 2022 and troughed at -$252000.0 in Q3 2024.
  • A 5-year average of $10.5 million and a median of $292000.0 in 2025 frame the typical range for Long-Term Debt Repayments.
  • The sharpest annual moves came in 2022 and 2024: Long-Term Debt Repayments surged 6364.45% in 2022, then slumped 281.25% in 2024.
  • A 5-year view of Long-Term Debt Repayments shows it stood at $167.5 million in 2022, then tumbled by 99.98% to $32000.0 in 2023, then tumbled by 281.25% to -$58000.0 in 2024, then jumped by 708.62% to $353000.0 in 2025, then sank by 38.81% to $216000.0 in 2026.
  • Business Quant data shows LNTH's Long-Term Debt Repayments at $216000.0 in Q1 2026, $353000.0 in Q4 2025, and $292000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 23.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 216,000.00
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 19.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 216,000.00
Mar 31, 2026 216,000.00
Dec 31, 2025 353,000.00
Dec 31, 2025 353,000.00
Sep 30, 2025 292,000.00
Sep 30, 2025 292,000.00
Jun 30, 2025 63,000.00
Jun 30, 2025 63,000.00
Mar 31, 2025 402,000.00
Mar 31, 2025 402,000.00
Dec 31, 2024 -58,000.00
Dec 31, 2024 -58,000.00
Sep 30, 2024 -252,000.00
Sep 30, 2024 -252,000.00
Jun 30, 2024 444,000.00
Jun 30, 2024 444,000.00
Mar 31, 2024 184,000.00
Mar 31, 2024 184,000.00
Dec 31, 2023 32,000.00
Dec 31, 2023 32,000.00